EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital.
about
Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature reviewPredictive biomarkers in precision medicine and drug development against lung cancerDistinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung CancerSequential treatment of icotinib after first-line pemetrexed in advanced lung adenocarcinoma with unknown EGFR gene status.A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression.Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South KoreaThe prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysisThe Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery.EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey.Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases.Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers.Harnessing plasma genotyping for precision therapy against lung cancer.Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations.EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.Establishment and characterization of a lung cancer cell line, SMC-L001, from a lung adenocarcinoma.Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study.Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR.Pathologic subtype-defined prognosis is dependent on both tumor stage and status of oncogenic driver mutations in lung adenocarcinoma.Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China.Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations.Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice?Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis.Erlotinib intercalating pemetrexed/cisplatin versus erlotinib alone in Chinese patients with brain metastases from lung adenocarcinoma: a prospective, non-randomised, concurrent controlled trial (NCT01578668).Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
P2860
Q26785713-D4D96D9A-114B-42B2-92FB-2A46C92CBEC1Q26824536-2161A6D3-7F62-4048-9D94-9DDC10C13056Q28387027-6AD56CC1-6E8A-41CE-86FB-FA2DE0EDFC81Q33995172-E9807E93-1C7B-43C6-B73D-2BF046BD4464Q34041754-A03A09C6-0A03-4154-A85B-374A3F76A759Q34538361-B0C36C71-38DB-4D9B-8593-E60A52AFBC67Q35961430-0C390324-8A20-4F8B-8E66-80777CE43324Q36092393-A00E810D-A839-4CDC-8ECE-1B7487ED5885Q36163279-303AB5EF-E8CF-4AA4-867C-28BC5738477BQ36243003-7206642C-BACC-416E-9896-C63CFEBCB211Q36250691-02B40D54-3E2C-48EC-BEAE-63C3A494050EQ36417758-EEA38473-DFAE-48EA-BB73-95FB72717233Q36924440-CE016885-A119-4D98-8AD6-081AB9B85D8EQ37269159-08E20780-98B2-4857-98B9-BA9DA68FD163Q37411128-3EA5B4E6-C2AF-4DB3-A086-7673E652B016Q38271717-BC3FFF9D-5533-4FEC-83AE-686C78FBEF15Q38373208-02DFCDD8-38CC-49DB-8BC9-8D2AD5649E8EQ38441068-695D4827-9C0D-45B0-8C0D-602F75018B16Q38995524-E914F1EF-2561-4EC3-9257-9BCDB88D22B0Q45719513-7D0CC288-0206-400F-8635-9DBFE160B218Q46603973-F51D4787-918D-4EB3-AAB0-846B3955D1E1Q47141165-2C5CC3E6-280B-480C-9C25-081D58DCFB6DQ47935277-34B39BF0-57B4-4C41-A905-277A74D9709BQ48478420-FD964716-5C57-477C-9216-922B87F83664Q53081976-785A59C6-0013-41CA-981C-E008A82C4A51Q54089180-A2F81E62-6471-4BE6-87DC-E98B96F945CBQ55261645-6D315AF8-CF0F-4FB5-9E7E-B01F9DCE55A0Q59137536-3F9C8854-D46E-46A4-81BE-7CAAB1E2ACAE
P2860
EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@ast
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@en
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@nl
type
label
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@ast
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@en
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@nl
prefLabel
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@ast
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@en
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@nl
P2093
P2860
P1433
P1476
EGFR mutation testing in patie ...... East Asian tertiary hospital.
@en
P2093
Bhash Parasuraman
Eliseo Guallar
Genehee Lee
Jeeyun Lee
Jong-Mu Sun
Joungho Han
Yoon-La Choi
Young Mog Shim
P2860
P304
P356
10.1371/JOURNAL.PONE.0056011
P407
P577
2013-02-28T00:00:00Z